Scarica l'app Stockscreener
310.02
0.76%
-2.37
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$312.39
Aprire:
$308.8
Volume 24 ore:
131.20K
Relative Volume:
0.54
Capitalizzazione di mercato:
$6.82B
Reddito:
$2.58B
Utile/perdita netta:
$-778.69M
Rapporto P/E:
-11.34
EPS:
-27.33
Flusso di cassa netto:
$223.75M
1 W Prestazione:
+4.13%
1M Prestazione:
+10.61%
6M Prestazione:
+30.16%
1 anno Prestazione:
-9.87%
Intervallo 1D:
$308.80
$313.63
Intervallo di 1 settimana:
$297.57
$322.29
Portata 52W:
$211.43
$387.99
Bio Rad Laboratories Inc Stock (BIO) Company Profile
Nome
Bio Rad Laboratories Inc
Settore
Industria
Telefono
(510) 724-7000
Indirizzo
1000 ALFRED NOBEL DRIVE, HERCULES
Confronta BIO con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
BIO
Bio Rad Laboratories Inc
|
310.02 | 8.45B | 2.58B | -778.69M | 223.75M | -27.33 |
|
ABT
Abbott Laboratories
|
128.54 | 222.13B | 43.84B | 13.94B | 6.78B | 7.9979 |
|
BSX
Boston Scientific Corp
|
99.24 | 144.89B | 18.49B | 2.50B | 3.49B | 1.6801 |
|
SYK
Stryker Corp
|
374.42 | 141.17B | 23.82B | 2.92B | 4.02B | 7.5574 |
|
MDT
Medtronic Plc
|
95.78 | 121.91B | 34.20B | 4.69B | 5.30B | 3.6218 |
|
EW
Edwards Lifesciences Corp
|
74.64 | 42.65B | 5.69B | 1.41B | 577.90M | 6.9828 |
Bio Rad Laboratories Inc Stock (BIO) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-10-01 | Aggiornamento | Citigroup | Neutral → Buy |
| 2024-08-28 | Iniziato | Wells Fargo | Equal Weight |
| 2024-06-03 | Ripresa | Jefferies | Hold |
| 2024-04-03 | Downgrade | Citigroup | Buy → Neutral |
| 2023-12-07 | Iniziato | UBS | Buy |
| 2023-06-16 | Iniziato | Wells Fargo | Overweight |
| 2022-12-07 | Iniziato | RBC Capital Mkts | Outperform |
| 2022-08-25 | Iniziato | Credit Suisse | Outperform |
| 2022-01-28 | Reiterato | Citigroup | Buy |
| 2020-01-08 | Iniziato | Wells Fargo | Overweight |
| 2020-01-07 | Iniziato | Citigroup | Buy |
| 2018-10-17 | Iniziato | Goldman | Buy |
| 2018-09-20 | Iniziato | Morgan Stanley | Equal-Weight |
| 2018-02-16 | Downgrade | CL King | Buy → Neutral |
| 2017-07-13 | Iniziato | Wells Fargo | Outperform |
| 2017-06-28 | Aggiornamento | Deutsche Bank | Hold → Buy |
| 2017-01-18 | Iniziato | Deutsche Bank | Hold |
| 2016-10-13 | Iniziato | CL King | Buy |
| 2015-05-06 | Reiterato | Jefferies | Buy |
| 2009-12-18 | Iniziato | Maxim Group | Buy |
| 2009-11-06 | Iniziato | Jefferies & Co | Buy |
| 2009-07-17 | Iniziato | Soleil | Buy |
| 2007-09-26 | Iniziato | Banc of America Sec | Buy |
| 2007-02-23 | Downgrade | Robert W. Baird | Outperform → Neutral |
Mostra tutto
Bio Rad Laboratories Inc Borsa (BIO) Ultime notizie
What analysts say about Bio Rad Laboratories Inc BUW stockFibonacci Extensions & Small Budget Trading Portfolio - earlytimes.in
Using Bollinger Bands to evaluate Bio Rad Laboratories Inc.Weekly Trade Analysis & Consistent Income Trade Ideas - newser.com
Technical Analysis: Will Bio Rad Laboratories Inc. stock gain from strong economyEarnings Overview Summary & Weekly Consistent Profit Watchlists - Trung tâm Dự báo KTTV quốc gia
Is Bio Rad Laboratories Inc. stock poised for growthJuly 2025 Macro Moves & Community Verified Swing Trade Signals - newser.com
Is Bio Rad Laboratories Inc. (BUWA) stock nearing a technical breakoutJuly 2025 Patterns & Fast Gain Stock Trading Tips - newser.com
Why Bio Rad Laboratories Inc. (BUW) stock stays resilient2025 EndofYear Setup & Risk Controlled Stock Pick Alerts - Trung tâm Dự báo KTTV quốc gia
Is Bio Rad Laboratories Inc. a candidate for recovery play2025 Dividend Review & Free Expert Verified Stock Movement Alerts - newser.com
How strong is Bio Rad Laboratories Inc. stock balance sheetJuly 2025 Fed Impact & High Accuracy Investment Signals - newser.com
Bio Rad Laboratories Inc Stock Analysis and ForecastDividend Cut Warnings & Build Wealth Brick by Brick With Us - earlytimes.in
Bio-Rad to Report Third Quarter 2025 Financial Results on Wednesday, October 29, 2025 - BioSpace
What analysts say about Bio Rad Laboratories Inc BUWA stockGap Fill Strategies & Free Trading Signals to Sharpen Your Edge - earlytimes.in
Bio-Rad To Report Third Quarter 2025 Financial Results - TradingView
Is Bio Rad Laboratories Inc. Class stock a top dividend aristocrat candidateJuly 2025 Review & Fast Gaining Stock Reports - newser.com
Is Bio Rad Laboratories Inc. stock a bargain at current levelsEarnings Recap Report & Long-Term Safe Investment Ideas - newser.com
[New Report] Life Science Reagents Market Share, Growth & Size - openPR.com
Does Bio Rad Laboratories Inc. qualify in momentum factor screeningWeekly Trend Summary & Real-Time Stock Price Movement Reports - newser.com
Bio-Rad Q2 2025 presentation: Life Science growth offsets diagnostics slowdown - Investing.com Australia
Top chart patterns to watch in Bio Rad Laboratories Inc.2025 Trading Volume Trends & Fast Moving Market Watchlists - newser.com
Earnings call transcript: Bio-Rad Labs Q2 2025 shows steady growth - Investing.com
How to build a custom watchlist for Bio Rad Laboratories Inc.Weekly Trend Recap & Reliable Intraday Trade Plans - newser.com
Chromatography Reagents Market Anticipated to Grow to USD 11.55 - openPR.com
Will Bio Rad Laboratories Inc. Class stock outperform value peersJuly 2025 Momentum & AI Powered Market Trend Analysis - newser.com
Bio-Rad To Distribute Gencurix Digital PCR Cancer Tests - Technology Networks
Is Bio Rad Laboratories Inc. (BUWA) stock protected from inflationJuly 2025 Chart Watch & Verified Momentum Watchlists - newser.com
Why ETFs are accumulating Bio Rad Laboratories Inc. Class B stockEarnings Recap Summary & Expert Verified Stock Movement Alerts - newser.com
Bio-Rad Laboratories, Inc. (BIO) Stock Analysis: Insights into a Healthcare Pioneer with 4.12% Upside Potential - DirectorsTalk Interviews
Hydroxyapatite Market to Witness Significant Growth from 2025 - openPR.com
Bio-Rad offers to acquire digital PCR developer Stilla Technologies - MSN
How buyback programs support Bio Rad Laboratories Inc. Class B stockJuly 2025 Weekly Recap & Stepwise Entry/Exit Trade Alerts - newser.com
What institutional flow reveals about Bio Rad Laboratories Inc.Trade Exit Summary & High Return Trade Opportunity Guides - newser.com
Sivik Global Healthcare LLC Makes New Investment in Bio-Rad Laboratories, Inc. $BIO - MarketBeat
Can Bio Rad Laboratories Inc. (BUW) stock resist broad market declinesJuly 2025 Sentiment & Long-Term Safe Investment Plans - newser.com
Bio-Rad Laboratories (NYSE:BIO.B) Stock Price Up 15.3%Here's What Happened - MarketBeat
Bio-Rad Laboratories (NYSE:BIO.B) Shares Gap UpWhat's Next? - MarketBeat
Bio-Rad Laboratories, Inc. $BIO Shares Sold by DAVENPORT & Co LLC - MarketBeat
KnowItAll Spectroscopy Software | Bio-Rad Laboratories Inc., Informatics Div. | New Products - Photonics Spectra
Will Bio Rad Laboratories Inc. (BUW) stock gain from lower interest ratesOil Prices & Reliable Entry Point Trade Alerts - newser.com
Can technical indicators confirm Bio Rad Laboratories Inc.’s reversalAnalyst Downgrade & Expert Curated Trade Ideas - newser.com
Will Bio Rad Laboratories Inc. see short term momentumJuly 2025 Highlights & Low Risk Entry Point Tips - newser.com
Newborn Screening Market Huge Growth in Future Scope 2025-2032 | Agilent Technologies, Inc., Bio-rad laboratories, Inc. - industrytoday.co.uk
Published on: 2025-10-10 05:39:23 - newser.com
Why Bio Rad Laboratories Inc. stock is favored by pension funds2025 Technical Overview & Fast Momentum Stock Entry Tips - newser.com
Market reaction to Bio Rad Laboratories Inc.’s recent newsPortfolio Update Summary & Weekly High Return Stock Opportunities - newser.com
945 Shares in Bio-Rad Laboratories, Inc. $BIO Acquired by Wealth Enhancement Advisory Services LLC - MarketBeat
Bio Rad Laboratories Inc Azioni (BIO) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.73%
0.04%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):